wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38724502-23DB3CDA-C25D-400E-B43B-BAF9A584CAE5
Q38724502-23DB3CDA-C25D-400E-B43B-BAF9A584CAE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38724502-23DB3CDA-C25D-400E-B43B-BAF9A584CAE5
The ESMO-Magnitude of Clinical Benefit Scale for novel oncology drugs: correspondence with three years of reimbursement decisions in Israel.
P2860
Q38724502-23DB3CDA-C25D-400E-B43B-BAF9A584CAE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38724502-23DB3CDA-C25D-400E-B43B-BAF9A584CAE5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f9dc40302b0805083dea49d7fe82de39637b14ef
P2860
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).